| pubmed-article:9564483 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9564483 | lifeskim:mentions | umls-concept:C0021311 | lld:lifeskim |
| pubmed-article:9564483 | lifeskim:mentions | umls-concept:C0021051 | lld:lifeskim |
| pubmed-article:9564483 | lifeskim:mentions | umls-concept:C0025952 | lld:lifeskim |
| pubmed-article:9564483 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:9564483 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:9564483 | lifeskim:mentions | umls-concept:C0006836 | lld:lifeskim |
| pubmed-article:9564483 | lifeskim:mentions | umls-concept:C0521367 | lld:lifeskim |
| pubmed-article:9564483 | lifeskim:mentions | umls-concept:C1516634 | lld:lifeskim |
| pubmed-article:9564483 | lifeskim:mentions | umls-concept:C0678226 | lld:lifeskim |
| pubmed-article:9564483 | lifeskim:mentions | umls-concept:C1261322 | lld:lifeskim |
| pubmed-article:9564483 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:9564483 | pubmed:dateCreated | 1998-6-11 | lld:pubmed |
| pubmed-article:9564483 | pubmed:abstractText | Signs and symptoms of oropharyngeal candidiasis (OPC) were correlated with microbiology and clinical response to fluconazole in a cohort of patients with advanced human immunodeficiency virus (HIV) infection and recurrent OPC. Sixty-four HIV-infected patients with a median CD4 cell count of < 50/mm3 (range, 3-318/mm3) who presented with OPC were enrolled in a longitudinal study. Specimens for cultures were taken weekly until clinical resolution. Therapy with fluconazole was increased weekly as required to a maximum daily dose of 800 mg until resolution of symptoms and oral lesions. Resistant or dose-dependent susceptible yeasts, defined as a minimum inhibitory concentration of > or = 16 micrograms/mL, were detected in 48 (31%) of 155 episodes. Clinical resolution with fluconazole therapy occurred in 107 (100%) of 107 episodes with susceptible yeasts vs. 44 (92%) of 48 episodes with resistant or dose-dependent susceptible strains (P = .008). Patients from whom fluconazole-resistant yeasts were isolated required longer courses of therapy and higher doses of fluconazole for response, but overall, excellent responses to fluconazole were seen in patients with advanced HIV infection. | lld:pubmed |
| pubmed-article:9564483 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9564483 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9564483 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9564483 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9564483 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9564483 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9564483 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9564483 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9564483 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:9564483 | pubmed:issn | 1058-4838 | lld:pubmed |
| pubmed-article:9564483 | pubmed:author | pubmed-author:ReddingS WSW | lld:pubmed |
| pubmed-article:9564483 | pubmed:author | pubmed-author:RinaldiM GMG | lld:pubmed |
| pubmed-article:9564483 | pubmed:author | pubmed-author:PattersonT... | lld:pubmed |
| pubmed-article:9564483 | pubmed:author | pubmed-author:FothergillA... | lld:pubmed |
| pubmed-article:9564483 | pubmed:author | pubmed-author:RevankarS GSG | lld:pubmed |
| pubmed-article:9564483 | pubmed:author | pubmed-author:KirkpatrickW... | lld:pubmed |
| pubmed-article:9564483 | pubmed:author | pubmed-author:McAteeR KRK | lld:pubmed |
| pubmed-article:9564483 | pubmed:author | pubmed-author:DibO POP | lld:pubmed |
| pubmed-article:9564483 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9564483 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:9564483 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9564483 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9564483 | pubmed:pagination | 960-3 | lld:pubmed |
| pubmed-article:9564483 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:9564483 | pubmed:meshHeading | pubmed-meshheading:9564483-... | lld:pubmed |
| pubmed-article:9564483 | pubmed:meshHeading | pubmed-meshheading:9564483-... | lld:pubmed |
| pubmed-article:9564483 | pubmed:meshHeading | pubmed-meshheading:9564483-... | lld:pubmed |
| pubmed-article:9564483 | pubmed:meshHeading | pubmed-meshheading:9564483-... | lld:pubmed |
| pubmed-article:9564483 | pubmed:meshHeading | pubmed-meshheading:9564483-... | lld:pubmed |
| pubmed-article:9564483 | pubmed:meshHeading | pubmed-meshheading:9564483-... | lld:pubmed |
| pubmed-article:9564483 | pubmed:meshHeading | pubmed-meshheading:9564483-... | lld:pubmed |
| pubmed-article:9564483 | pubmed:meshHeading | pubmed-meshheading:9564483-... | lld:pubmed |
| pubmed-article:9564483 | pubmed:meshHeading | pubmed-meshheading:9564483-... | lld:pubmed |
| pubmed-article:9564483 | pubmed:meshHeading | pubmed-meshheading:9564483-... | lld:pubmed |
| pubmed-article:9564483 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9564483 | pubmed:articleTitle | Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patients. | lld:pubmed |
| pubmed-article:9564483 | pubmed:affiliation | University of Texas Health Science Center at San Antonio 78284-7881, USA. | lld:pubmed |
| pubmed-article:9564483 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9564483 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:9564483 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9564483 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9564483 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9564483 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9564483 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9564483 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9564483 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9564483 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9564483 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9564483 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9564483 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9564483 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9564483 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9564483 | lld:pubmed |
